Discovery of RNA-degrading mechanism can open for new class of diabetes drugs
Researchers from University of Copenhagen have discovered exactly how inflammation hinders insulin production in patients with type 2 diabetes. According to one of the professors, the discovery could bring about a whole new class of diabetes drugs based on one of the most promising fields of biotechnology: RNA.
Researchers from University of Copenhagen (UCPH) are the first ever to discover exactly how inflammation disturbs the insulin production in patients with type 2 diabetes.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
